These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 7448732)

  • 21. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer.
    Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K
    Anticancer Res; 1988; 8(4):647-51. PubMed ID: 2972248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment.
    Søreide JA; Lea OA; Varhaug JE; Skarstein A; Kvinnsland S
    Eur J Surg Oncol; 1992 Apr; 18(2):112-8. PubMed ID: 1582503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Steroid hormone receptors in breast cancer].
    Nomura Y
    Rinsho Byori; 1990 Jan; 38(1):26-30. PubMed ID: 2308219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a displacement assay with tamoxifen as prognostic indicator in breast-cancer patients with estrogen-receptor-positive tumors.
    Levin E; Actis AM; Caruso S; Gass H; Romero R; Qualeta N; Levin RW
    Int J Cancer; 1997 Nov; 73(4):486-91. PubMed ID: 9389560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective analysis of time to recurrence in the ATAC trial according to hormone receptor status: an hypothesis-generating study.
    Dowsett M; Cuzick J; Wale C; Howell T; Houghton J; Baum M
    J Clin Oncol; 2005 Oct; 23(30):7512-7. PubMed ID: 16234518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic significance of steroid receptor activity in tumor tissues of patients with primary breast cancer.
    Hupperets PS; Volovics L; Schouten LJ; Jager JJ; Schouten HC; Hillen HF; Blijham GH
    Am J Clin Oncol; 1997 Dec; 20(6):546-51. PubMed ID: 9391537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steroid receptors in breast cancer.
    Desombre ER
    Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer.
    Zeillinger R; Kury F; Czerwenka K; Kubista E; Sliutz G; Knogler W; Huber J; Zielinski C; Reiner G; Jakesz R
    Oncogene; 1989 Jan; 4(1):109-14. PubMed ID: 2915900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression.
    Balduzzi A; Bagnardi V; Rotmensz N; Dellapasqua S; Montagna E; Cardillo A; Viale G; Veronesi P; Intra M; Luini A; Pruneri G; Mastropasqua G; Goldhirsch A; Colleoni M
    Clin Breast Cancer; 2014 Aug; 14(4):258-64. PubMed ID: 24325948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study.
    Elledge RM; Green S; Pugh R; Allred DC; Clark GM; Hill J; Ravdin P; Martino S; Osborne CK
    Int J Cancer; 2000 Mar; 89(2):111-7. PubMed ID: 10754487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of tamoxifen on the tumor content of steroid hormone receptors (ER, PgR and AR) in patients with primary breast cancer.
    Lundgren S; Søreide JA; Lea OA
    Anticancer Res; 1994; 14(3B):1313-6. PubMed ID: 8067700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical study of hormone receptor and hormone-regulated protein expression in phyllodes tumour: comparison with fibroadenoma.
    Umekita Y; Yoshida H
    Virchows Arch; 1998 Oct; 433(4):311-4. PubMed ID: 9808432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between steroid receptors and response to endocrine therapy and cytotoxic chemotherapy in metastatic breast cancer.
    Young PC; Ehrlich CE; Einhorn LH
    Cancer; 1980 Dec; 46(12 Suppl):2961-3. PubMed ID: 7448744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adjuvant endocrine forms of therapy in breast cancer].
    Jakesz R; Hausmaninger H
    Wien Klin Wochenschr; 1984 Jun; 96(13):492-9. PubMed ID: 6475078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer.
    Foekens JA; Portengen H; Look MP; van Putten WL; Thirion B; Bontenbal M; Klijn JG
    Br J Cancer; 1994 Dec; 70(6):1217-23. PubMed ID: 7981080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer.
    Chan M; Chang MC; González R; Lategan B; del Barco E; Vera-Badillo F; Quesada P; Goldstein R; Cruz I; Ocana A; Cruz JJ; Amir E
    PLoS One; 2015; 10(7):e0132449. PubMed ID: 26161666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer.
    Reiner A; Neumeister B; Spona J; Reiner G; Schemper M; Jakesz R
    Cancer Res; 1990 Nov; 50(21):7057-61. PubMed ID: 2208173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histochemical assay of estrogen and progesterone receptors in breast cancer: correlation with biochemical assays and patients' response to endocrine therapies.
    Pertschuk LP; Tobin EH; Gaetjens E; Carter AC; Degenshein GA; Bloom ND; Brigati DJ
    Cancer; 1980 Dec; 46(12 Suppl):2896-901. PubMed ID: 6256056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: a multivariate analysis approach.
    Brentani MM; Franco EL; Oshima CT; Pacheco MM
    Int J Cancer; 1986 Nov; 38(5):637-42. PubMed ID: 3770993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.